Speaker illustration

Ms Huai-Wen Liang

E-Da hospital, Kaohsiung (Taiwan)

Baseline characteristics, treatment dosage, and clinical outcomes of post-acute HFrEF patients initiated with Sacubitril/Valsartan

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Thumbnail

This platform is supported by

logo Novo Nordisk